Thus, serum Ang2 level is a candidate biomarker for the presence of liver diseases such as nonalcoholic steatohepatitis (NASH) [35] and mortality in decompensated LC with kidney dysfunction [36]. Here, ANGPT2 is linked to laryngotracheoesophageal cleft.